Duration
10h Th
Number of credits
Lecturer
Language(s) of instruction
French language
Organisation and examination
Teaching in the second semester
Schedule
Units courses prerequisite and corequisite
Prerequisite or corequisite units are presented within each program
Learning unit contents
This course provides an overview of Advanced Therapy Medicinal Products (ATMPs) and selected nucleic acid-based medicines currently used in clinical practice.
The course covers:
- Gene Therapy Medicinal Products (GTMPs)
- Somatic Cell Therapy Medicinal Products (CTMPs)
- Tissue Engineered Products (TEPs)
- Combined Advanced Therapy Medicinal Products
- Medicines based on messenger RNA (mRNA) and small interfering RNA (siRNA)
Learning outcomes of the learning unit
The objective of this course is to provide students with the fundamental knowledge required to understand advanced therapy medicinal products (ATMPs), their therapeutic strategies, mechanisms of action, regulatory framework, and the scientific, technological and practical challenges associated with their development and clinical implementation.
Prerequisite knowledge and skills
Planned learning activities and teaching methods
This course is based on lectures delivered face to face.
During some sessions, interactive Wooclap activities may be organized to review the knowledge covered in the previous lecture(s). These Wooclap sessions are intended to allow students to assess their continuous understanding and to prepare them for the final examination.
Mode of delivery (face to face, distance learning, hybrid learning)
Face-to-face course
Course materials and recommended or required readings
Platform(s) used for course materials:
- eCampus
- MyULiège
Further information:
A copy of the slides presented during the course is available online.
Videos illustrating specific concepts discussed during the course are also available online.
Exam(s) in session
Any session
- In-person
written exam ( multiple-choice questionnaire, open-ended questions )
Further information:
The assessment is a written examination that may include multiple-choice questions (MCQs) and/or open-ended questions.
Work placement(s)
Organisational remarks and main changes to the course
Contacts
Manon BERGER, Laboratory of Pharmaceutical Technology and Biopharmacy (LTPB), mberger@uliege.be
Professeur Géraldine PIEL, Laboratory of Pharmaceutical Technology and Biopharmacy (LTPB), geraldine.piel@uliege.be